Virion Biotherapeutics

(Image: Getty/Rawpixel)

Hired and Retired: Transitions at the top

By Ben Hargreaves

In a significant move at the larger end of the biopharma world, AstraZeneca’s global VP of cardiovascular, renal and metabolism made the move to Novo Nordisk to head up its biopharm unit.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All